期刊文献+

血栓性微血管病9例临床分析

Clinical analysis of nine patients with thrombotic microangiopathy
下载PDF
导出
摘要 [目的]了解血栓性微血管病(Thrombotic microangiopathy,TMA)的临床特征及治疗,结合文献探讨其发病机制以加深对该病的认识。[方法]对9例TMA患者的临床表现特点、治疗及预后进行回顾性分析。[结果]患者主要临床表现为微血管病性贫血(9/9),血小板减少(9/9),乳酸脱氢酶升高(9/9),不同程度的肾脏损害和中枢神经系统症状(9/9),发热(5/9);6例治愈,3例死亡。[结论]TMA起病急、进展快、死亡率高、预后差,应提高对本病的认识,早诊断、早治疗、减少死亡率。 [Objective] To study the clinical characteristics and treatment of thrombotic microangiopathy(TMA) for improve recognition of TMA,combined with reviewing literatures.[Methods] Clinical data including manifestation,treatment and prognoses of 9 patients with TMA admitted to our hospital between January 2007 and December 2010 were analyzed retrospectively.[Results] The clinical manifestation was characterized by microangiopathic hemolytic anemia(9/9),thrombocytopenia(9/9),elevated serum LDH value(9/9),renal damage and neurological abnormalitics(9/9) and fever(5/9).Six of the patients were cured and 3 of them died.[Conclusion] TMA is a kind of severe acute syndrome with high mortality and bad prognosis.We should improve recognition of TMA for quick diagnosis and treatment in order to obtain better efficacy and less mortality.
出处 《大连医科大学学报》 CAS 2011年第3期248-252,共5页 Journal of Dalian Medical University
关键词 血栓性微血管病 临床分析 发病机制 thrombotic microangiopathy clinical analysis pathogenesis
  • 相关文献

参考文献16

  • 1张之南主编..血液病诊断及疗效标准 第2版[M].北京:科学出版社,1998:434.
  • 2Joel Moake.Thrombotic thrombocytopenia purpura (TTP)and other thrombotic microangiopathies[J].Best Pract Res Cl Ha,2009,(22):567-576. 被引量:1
  • 3Moake JL.Thrombotic microangiopathies[J].N Engl J Med,2002,347:589-600. 被引量:1
  • 4Mannucci PM,Canciani MT,Forza I,et al.Changes in health and disease of the metalloprotease that cleaves yon Willebrand factor[J].Blood,2001,98:2730-2735. 被引量:1
  • 5Bernardo A,Ball C,Nolasco L,et al.Effects of inflammatory cytokines on the release and cleavage of the endothelial cellderived ultralarge von Willebrand factor multimers under flow[J].Blood,2004,104:100-106. 被引量:1
  • 6Nolasco LH,Turner NA,Bemardo A,et al.Hemolytic uremic syndromeassociated Shiga toxins promote endothelial -cell secretion and impair ADAMTS13 cleavage of unusually large yon Willebrand factor multimers[J].Blood,2005,106:4199 -4209. 被引量:1
  • 7Richards A,Goodship JA,Goodship TH.The genetics and pathogenesis of hemolytic uraemic syndrome and thrombotic thrombocytopenic purpura[J].Curt Opin Nephrol Hypertens,2002,11:431-435. 被引量:1
  • 8Caprioli J,Noris M,Brioschi S,et al.Genetics of HUS:the impact of MCP,CFH,and IF mutations on clinical presentation,response to treatment,and outcome[J].Blood,2006,108:1267-1279. 被引量:1
  • 9Mutter WP,Karumanchi SA.Molecular mechanisms of preeclampsia[J].Microvasc Res,2008,75:1-8. 被引量:1
  • 10Bell WR,Braine HG,Ness PM,et al.Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.Clinical experience in 108 patients[J].N Engl J Med,1991,325:398-403. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部